IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway ; volume:18 ; number:1 ; day:30 ; month:5 ; year:2018 ; pages:1-10 ; date:12.2018
BMC cancer ; 18, Heft 1 (30.5.2018), 1-10, 12.2018

Creator: Huang, Wei-Chieh

Contributor: Tung, Shiao-Lin
Chen, Yao-Li
Chen, Po-Ming
Chu, Pei-Yi
SpringerLink (Online service)

DOI: 10.1186/s12885-018-4529-9

URN: urn:nbn:de:101:1-2018080623413824218891

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Huang, Wei-Chieh
Tung, Shiao-Lin
Chen, Yao-Li
Chen, Po-Ming
Chu, Pei-Yi
SpringerLink (Online service)

Other Objects (12)

Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling

TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling

Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

Graffiti | Streetart

SRC

Graffiti | Streetart

SRC

Graffiti | Streetart

SRC

RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer

Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling

TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling

Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

Graffiti | Streetart

SRC

Graffiti | Streetart

SRC

Graffiti | Streetart

SRC

RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer

Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling

TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling

Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

Graffiti | Streetart

SRC

Graffiti | Streetart

SRC

Graffiti | Streetart

SRC

RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling

TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling

Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

SRC

SRC

SRC

RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer

Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling

TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling

Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

SRC

SRC

SRC

RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer

Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling

TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling

Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

SRC

SRC

SRC

RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer

Related objects

Reset password